sofosbuvir has been researched along with Kidney Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Awad, J; Balsara, K; Brinkley, DM; Brown Sacks, S; Danter, M; Darragh, C; Fowler, R; Lindenfeld, J; Menachem, J; O'Dell, H; Ooi, H; Perri, R; Punnoose, L; Ruzevich-Scholl, S; Schlendorf, K; Shah, A; Smith, S; Wigger, M; Zalawadiya, SK | 1 |
| Akhil, MS; Arumugam, K; Ganesh Prasad, NK; Kirushnan, B; Martin, M; Ravichandran, R | 1 |
| Durante-Mangoni, E; Parrella, A; Vitrone, M | 1 |
| Dashti-Khavidaki, S; Khalili, H; Nasiri-Toosi, M | 1 |
| Aljudaibi, B; Bilodeau, M; Congly, SE; Faisal, N; Ghali, MP; Hirch, G; Hussaini, T; Lilly, LB; Ma, MM; Yoshida, EM | 1 |
| Butt, AA; Marks, K; Ren, Y; Shaikh, OS; Sherman, KE | 1 |
1 review(s) available for sofosbuvir and Kidney Diseases
| Article | Year |
|---|---|
Potential nephrotoxicity of sofosbuvir-based treatment in patients infected with hepatitis C virus: a review on incidence, type and risk factors.
Topics: Acute Kidney Injury; Antiviral Agents; Drug Monitoring; Hepatitis C; Humans; Incidence; Kidney Diseases; Kidney Function Tests; Risk Factors; Sofosbuvir; Time Factors | 2018 |
5 other study(ies) available for sofosbuvir and Kidney Diseases
| Article | Year |
|---|---|
Trends in Renal Function Among Heart Transplant Recipients of Donor-Derived Hepatitis C Virus.
Topics: Adult; Antiviral Agents; Benzimidazoles; Carbamates; Drug Therapy, Combination; Female; Fluorenes; Heart Transplantation; Hepatitis C; Heterocyclic Compounds, 4 or More Rings; Humans; Kidney Diseases; Male; Middle Aged; Sofosbuvir; Sustained Virologic Response; Tissue Donors; Transplant Recipients; Uridine Monophosphate | 2020 |
Sofosbuvir-based treatment is safe and effective in Indian hepatitis C patients on maintenance haemodialysis: A retrospective study.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Carbamates; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C; Humans; Imidazoles; India; Kidney Diseases; Male; Middle Aged; Pyrrolidines; Renal Dialysis; Retrospective Studies; Ribavirin; Sofosbuvir; Sustained Virologic Response; Time Factors; Treatment Outcome; Valine; Viral Load | 2018 |
Reply to Letter: Influence of Liver and Kidney Disease on Sofosbuvir Electrophysiological Effects.
Topics: Antiviral Agents; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney Diseases; Sofosbuvir | 2017 |
Impact of Sofosbuvir-Based Regimens for the Treatment of Hepatitis C After Liver Transplant on Renal Function: Results of a Canadian National Retrospective Study.
Topics: Aged; Antiviral Agents; Canada; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hepatitis C; Humans; Kidney; Kidney Diseases; Liver Transplantation; Male; Middle Aged; Recovery of Function; Recurrence; Retrospective Studies; Sofosbuvir; Sustained Virologic Response; Time Factors; Treatment Outcome | 2019 |
Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES.
Topics: Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney Diseases; Liver Cirrhosis; Liver Transplantation; Male; Risk Factors; Ritonavir; Simeprevir; Sofosbuvir | 2017 |